Edition:
India

Rhythm Pharmaceuticals Inc (RYTM.OQ)

RYTM.OQ on NASDAQ Stock Exchange Global Market

29.04USD
22 Jan 2018
Change (% chg)

$1.15 (+4.12%)
Prev Close
$27.89
Open
$28.00
Day's High
$29.19
Day's Low
$28.00
Volume
20,759
Avg. Vol
--
52-wk High
$33.80
52-wk Low
$21.38

Chart for

About

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. The Company’s lead peptide product candidate is setmelanotide, a potent,... (more)

Overall

Beta: --
Market Cap(Mil.): $685.07
Shares Outstanding(Mil.): 27.13
Dividend: --
Yield (%): --

Financials

BRIEF-Rhythm Pharmaceuticals Announces Progress In Clinical Development Of Setmelanotide

* RHYTHM PHARMACEUTICALS ANNOUNCES PROGRESS IN CLINICAL DEVELOPMENT OF SETMELANOTIDE FOR TREATMENT OF RARE GENETIC DISORDERS OF OBESITY

04 Jan 2018

BRIEF-Rhythm Pharmaceuticals reports Q3 loss of $1.78/shr

* Rhythm Pharmaceuticals reports third quarter 2017 financial results

14 Nov 2017

Earnings vs. Estimates